(Q42556526)

English

Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: a six-month masked, multicenter trial in the United States. The United States Latanoprost Study Group

scientific article published on January 1996

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

2 November 2017

Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: a six-month masked, multicenter trial in the United States. The United States Latanoprost Study Group (English)

1 reference

Europe PubMed Central

2 November 2017

0 references

multicenter clinical trial

1 reference

based on heuristic

inferred from title

ocular hypertension

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

United States of America

1 reference

based on heuristic

inferred from title

author name string

Camras CB

1

1 reference

Europe PubMed Central

2 November 2017

publication date

1 January 1996

1 reference

Europe PubMed Central

2 November 2017

1 reference

Europe PubMed Central

2 November 2017

103

1 reference

Europe PubMed Central

2 November 2017

1

1 reference

Europe PubMed Central

2 November 2017

138-147

1 reference

Europe PubMed Central

2 November 2017

Prostaglandin F2 alpha-isopropylester eye drops: effects in normal human eyes

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930749-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostaglandin F2 alpha-isopropylester eye drops: effect on intraocular pressure in open-angle glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930749-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Ocular effects of two different prostaglandin F2 alpha esters. A doublemasked cross-over study on normotensive eyes

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930749-5

7 January 2021

based on heuristic

inferred from DOI database lookup

PhXA34, a new potent ocular hypotensive drug. A study on dose-response relationship and on aqueous humor dynamics in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930749-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of prostaglandin D2 and its analogue, BW245C, on intraocular pressure in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930749-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Intraocular pressure reduction with PhXA34, a new prostaglandin analogue, in patients with ocular hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930749-5

7 January 2021

based on heuristic

inferred from DOI database lookup

PhXA34--a prostaglandin F2 alpha analogue. Effect on intraocular pressure in patients with ocular hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930749-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of PhXA41, a new prostaglandin F2 alpha analog, on aqueous humor dynamics in human eyes

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930749-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Intraocular pressure-reducing effect of PhXA41 in patients with increased eye pressure. A one-month study

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930749-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Intraocular pressure-reducing effect of PhXA41 in ocular hypertension. Comparison of dose regimens

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930749-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Maintained intraocular pressure reduction with once-a-day application of a new prostaglandin F2 alpha analogue (PhXA41). An in-hospital, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930749-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The effects on aqueous dynamics of PhXA41, a new prostaglandin F2 alpha analogue, after topical application in normal and ocular hypertensive human eyes

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930749-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Phenyl-substituted prostaglandins: potent and selective antiglaucoma agents

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930749-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The effects of prostaglandin F2 alpha in the human eye

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930749-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of adding prostaglandin F2 alpha-isopropylester to timolol in patients with open angle glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930749-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Additivity of prostaglandin F2 alpha-1-isopropyl ester to timolol in glaucoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930749-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Nocturnal arterial hypotension and its role in optic nerve head and ocular ischemic disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930749-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0161-6420(96)30749-5

1 reference

Europe PubMed Central

2 November 2017

1 reference

Europe PubMed Central

2 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42556526&oldid=1961502760"